Start typing to search across the full knowledge system.
Transparency log
Errors should become visible evidence of correction, not disappear silently. Material changes to published investigations are logged here.
Corrected the description of Alpha Audio power-conditioner testing: its accessible article describes the Prism dScope setup, but the numerical noise results and any blinded audible-benefit outcome were not independently verified; the verdict remains Inconclusive / Low.
Corrected the Bermuda Triangle evidence status from Contradicted / Moderate to Unsupported / Low: the 2022 casualty study lacked shipping and flight-exposure denominators and cannot establish a matched regional disappearance-rate comparison.
Added an empirical winter cloud-seeding study as evidence of limited local snowfall modification and distinguished it from claims of controlling large storms; the conclusion remains Contradicted.
Clarified original human vitamin C comparisons: steady-state measures were broadly similar, while a small crossover study found higher urinary excretion after kiwifruit; the conclusion remains Contradicted.
Added a publicly reported 2025 distant-planet search candidate to distinguish open detection research from evidence of a secretly confirmed Earth-approaching planet; the conclusion remains Unsupported.
Added a 2025 infrared search reporting one unconfirmed distant Planet Nine candidate and clarified that it provides neither a measured orbit nor evidence of Nibiru entering the inner Solar System; the conclusion remains Contradicted.
Added court-verified generic-drug competition evidence and recalibrated Evidence Quality from High to Moderate for the much broader unproven universal-cure claim; Evidence Status remains Unsupported.
Evidence update: incorporated the 2025 and 2026 externally beam-driven fusion findings, separating genuine reaction-rate results from unverified practical net-energy claims; Evidence Status unchanged.
Evidence update: specified the 2016 review's 25-publication, 16-original-data scope and the exposure-meter validity caveat; claim and status unchanged.
Clarification: 2025 Connecticut appeal directed one Mallove-murder defendant’s convictions vacated and a new trial; separated prosecution theory from final findings. Evidence Status unchanged.
Editorial clarification: explained NASA exploratory task results and distinguished them from proof of operational gravity control; status unchanged.
Substantive scope and status revision: restricted the Claim to closed self-powered water-fuel engines and the hiding of those specific alleged working devices; changed Evidence Status Unsupported to Contradicted, Quality High retained. Actual externally powered hydrogen systems remain outside scope.
Evidence update: added named historical patch testing and study-level measurements from a 20-pendant radionuclide sample; claim and status unchanged.
Editorial clarification: distinguished declassified human technical history and AARO review findings from authenticated alien-artifact transfer; status unchanged.
Evidence update: assessed the 2024 baby-monitor pilot and applied the published review corrigendum removing a duplicated report (40 studies, 2,857 people) and correcting sleep estimates; Evidence Status unchanged.
Scope clarification: narrowed to freezing/thawing of drinking water, explicitly separating proprietary imprinted water and other processing from the tested proposition; Evidence Status unchanged.
Editorial clarification: distinguished transmission and genuine posthumous records from proof of a functional limitless-energy generator; status unchanged.
Clarified the discrepancy between Plato's chronology and the Thera eruption and added specialist literary context; conclusion unchanged.
Added archaeological evidence of ancient pathological gigantism and distinguished a documented unusually tall individual from an unverified suppressed population; conclusion unchanged.
Added Caral dating and Giza construction archaeology and clarified that Caral's chronology partly overlaps ancient Egypt; conclusion unchanged.
Added Pahl's published corridor-length numerical proposal and distinguished the 1975 speed-of-light value from the 1983 SI metre definition; conclusion unchanged.
The earlier Contradicted / High verdict relied on orbital observations of the ISS to address a separate question about the origin of onboard footage. The revised Unsupported / Moderate conclusion distinguishes station observations, clip-specific provenance and the ground-correlated ILAN-ES camera experiment.
Added Broadbent's Cornwall alignment test and clarified that a local spatial simulation does not directly test a global physical energy field; conclusion unchanged.
Narrowed this investigation to temporarily softening already-solid hard rock; moved the separate pyramid cast-limestone question to its own Investigation; Unsupported / Moderate unchanged.
Separated the nuclear-physical hypothesis from the disputed instant-massacre skeleton narrative in a separate Investigation; changed the nuclear-only Evidence Status from Contradicted to Unsupported, Quality Moderate unchanged.
Expanded the distinction between ancient giant narratives and physical evidence for monument builders, including excavated human workforce infrastructure; conclusion unchanged.
Added an authenticated eighteenth-century Tartary map and explained why historical geographic labels do not establish one erased technological world-state; conclusion unchanged.
Added Seattle's documented post-1889 street-level rebuilding as a local explanation for buried-looking urban floors; conclusion unchanged.
Editorial clarification: strengthened glass-ingestion warnings and added Online Challenges & Claims as contextual classification after documenting challenge-framed online media; the precise Claim, Evidence and Contradicted / Moderate conclusion remain unchanged.
Corrected interpretation of the 42-person dental study using baseline-adjusted cortisol comparison, documented 2019 crossover corrigendum favoring 440 Hz on tiredness, and kept small positive sleep findings. Unsupported / Moderate unchanged.
Material evidence and scope update: split the former combined black-hole/portal claim; the original permanent article now evaluates Earth-threatening growth only; its status changed from Unsupported to Contradicted using conservative astrophysical constraints. The microscopic-black-hole production and portal allegations are covered in separate Investigations.
Integrated the 2016 corrected expert survey and 2026 GAO audit, clarifying that real weather modification and imperfect reporting do not establish secret airline spraying. Evidence Quality recalibrated from High to Moderate without changing Unsupported.
Introduced the 183-church alignment study and explicitly separated archaeological orientation from unmeasured extractable planetary or human energy. Unsupported / Moderate unchanged.
Linked original Wadi el-Jarf excavation record and the same excavator's 2026 synthesis to independent Giza settlement archaeology, separating known Egyptian logistics from unsettled lifting techniques. Contradicted / High unchanged.
Added quantitative evidence from a direct 2020 HAARP ionospheric experiment and distinguished plasma measurements from lower-atmosphere weather. Evidence Status Contradicted and Quality High unchanged.
Added original induced-seismicity analysis and contrasted subterranean fault stress with HAARP ionosphere measurements. Evidence Quality recalibrated from High to Moderate without changing Contradicted.
Separated authenticated Khufu muon voids, the August 2026 retraction of a 2022 Khufu SAR paper, and the independently unvalidated 2025 Khafre city claims. Evidence Quality recalibrated High to Moderate without changing Unsupported.
Added 20-device pendant gamma-spectrometry findings and distinguished measured radioactivity and modeled radiation dose from clinical efficacy. Unsupported / Moderate unchanged.
Defined material impenetrable dome as preventing real spaceflight; restored Contradicted / High while distinguishing untestable alternatives.
Added NIST liquid-water formation enthalpy and explicitly distinguished reaction enthalpy, reversible electrical work and external heat; water-only closed-cycle verdict Contradicted / High unchanged.
Editorial update: Added a 2023 measured granite-work-rate experiment and separated physical tool capability from the diagnostic evidence a laser hypothesis would require. Evidence Status remains unchanged.
Editorial update: Added adversarial quantitative granite-working evidence and qualified the limits of individual experimental reconstructions. Evidence Status remains unchanged.
Distinguished independent radio tracking, original lunar rock lab results and robotic reflector limits.
Editorial update: Clarified the distinction between installed approximately 1,000-tonne podium stones and an approximately 1,650-tonne unfinished quarry block, using original excavation documentation. Evidence Status remains unchanged.
Editorial update: Added a 2026 quantitative reconstruction, the electrolyte and collector conditions, and the distinction between laboratory voltage and ancient intention. Evidence Status remains unchanged.
Corrected the 2014 study description from intervention to observational, added the 2021 68-person vegan-diet subgroup analysis, and changed Evidence Status to Unsupported and Evidence Quality to Moderate.
Clarified literal chemical composition versus meaningful restrictions on named ingredients and their detection limits; broad verdict unchanged.
Source update: historical CORONA and A-12 classified programs were documented while distinguishing actual secrecy precedents from evidentiary support for unrelated extraordinary claims; the Misleading verdict remains unchanged.
Editorial update: Narrowed the proposition to two identified museum skulls and specified the laboratory comparator samples and technical limitations. Evidence Status remains unchanged.
Qualified physical geometry verdict and independent concealment allegation
Added the original EFSA E171 assessment and EU 2022 food authorization withdrawal, distinguishing chemical-specific genotoxicity concern from a general E-number hazard label; broad verdict unchanged.
Evidence Quality update: actual patent-secrecy orders are separated from unverified over-unity machine function and systematic suppression; Evidence Quality changed from High to Moderate while Unsupported status remains unchanged.
Added original MON810 and NK603 feeding studies, opposing Séralini findings, and the 2020 NK603 publisher correction with male subgroup observations; broad verdict unchanged.
Added original gravitation experiments with measured values and acknowledged calibration limitations.
Editorial update: Updated original Giza construction evidence and clarified the distinction between confirmed archaeological context and speculative energy mechanisms. Evidence Status remains unchanged.
Updated the evidence comparison: WHO deficiency-prevention trials versus thyroid risk when total iodine intake is excessive, including the 2025 autoimmunity review; broad verdict unchanged.
Clarification and source update: magnetic work, restoration of the initial configuration and the full load and loss budget are distinguished; the Contradicted verdict remains unchanged.
Added original broccoli vitamin C retention measurements and opposing leafy-vegetable vitamin K losses, distinguishing food assays from clinical nutrition outcomes; broad verdict unchanged.
Distinguished non-ionizing microwave heating from radioactive food and ionizing radiation, with actual FDA leakage standards and damaged-oven caveats; broad verdict unchanged.
Scope clarification: the former combined recovered-electronics origin allegation is narrowed to the transistor, with integrated circuits, lasers and fiber optics assessed in separate new Investigations; Unsupported remains unchanged.
Added the original blinded high-dose MSG challenge and EFSA exposure limits, distinguished transient symptoms from neurological injury, and changed Evidence Quality from High to Moderate.
Added natural aflatoxin carcinogenic hazard and product-specific exposure comparisons, and changed Evidence Quality from High to Moderate.
Evidence update: a directly relevant 2015 orgonite appliance study and a distinct Polish institutional test of a related radiation neutralizer were added with device-identity and measurement limitations; the Unsupported verdict remains unchanged.
Evidence update: FY2025 U.S. invention-secrecy order statistics were added while keeping legal classification distinct from proof of energy-device performance or industrial motive; the Misleading verdict remains unchanged.
Clarification and source update: the complete energy-input boundary and a 2024 externally powered electromagnetic demonstration were added; the Contradicted verdict remains unchanged.
Editorial update: Added actual experimental results including the incomplete flattening of recessed trial surfaces and a bounded production-time estimate. Evidence Status remains unchanged.
Scope clarification and evidence update: nonstandard pyramid energy is separated from conventional externally excited radio-wave modeling, and primary milk-microbe and 2024 packaging experiments are discussed with their confounding limitations; the Unsupported verdict remains unchanged.
Editorial update: Separated the original compound claim into transport only; erection is evaluated independently in the separate moai-erection Investigation. Added 1998 transport comparison and qualified corrected 2025 data. Evidence Status remains unchanged.
Distinguished measured vacuum electrical microthruster recoil from unmatched chemical-engine performance data.
Editorial update: Added site-specific original masonry-fitting analysis and kept unsolved handling and transport distinct. Evidence Status remains unchanged.
Separated satellite nonexistence from the undefined relative use of ground networks.
Added Sydney and Minnesota randomized mortality evidence and the updated Cochrane omega-6 synthesis, and changed Evidence Status to Misleading and Evidence Quality to Moderate.
Added original planetary radar and Gaia parallax evidence, calibration and access limitations.
Source update: original 1948 transistor and 1959 integrated-circuit patent records now explicitly document the human development sequence; the Contradicted verdict remains unchanged.
Evidence update: positive but unsettled 2019 gas-flow radiation and 2021 microscopic cavity-current experiments were added, distinguishing measured 1.4 picowatts from normalized 70 W/m2 and from usable net generation; Unsupported remains unchanged.
Integrated original rocket and satellite observations, distinguishing real escape from immediate total loss.
Inserted original Apollo 10 dosimeter readings and distinguished integrated dose from peak dose rate.
Added original quantitative Jurassic polar-wander study and distinguished magnetic reversals, true polar wander and historical rotation-axis changes.
Evidence clarification: 2018 and 2020 patient-data analyses reuse overlapping trial populations; the incremental benefit over sham remains modest and condition-dependent.
Added Trinh et al. 2024 pooled observational OR 0.96 (95% CI 0.78–1.17; I2 60%), while retaining a positive 2017 high-use subgroup and aluminum-specific causal uncertainty. Verdict Inconclusive / Moderate unchanged.
Specified the 178 treated/175 evaluable uncontrolled regimen, one ten-week partial response, subsequent progression, 2022 NCI PDQ context and cyanide hazard; no convincing human treatment benefit. Contradicted / Moderate unchanged.
Detailed the Bangladesh cluster trial's published reanalysis and denominator/symptom ascertainment limits. Mask benefits remain heterogeneous; Misleading / Moderate unchanged.
Added a 2026 Australian ecological excess-mortality argument with explicit abstract-only access and individual-level causal limits, alongside linked cohort evidence. Contradicted / Moderate unchanged.
Added strongest local cultural-memory examples and opposing Black Sea original/synthesis interpretations, with clear full-source-access limitations.
Clarified the difference between regulatory advertising enforcement and experimental toxin clearance, including stipulated-order nonadmission. Verdict Unsupported / Moderate unchanged.
Evidence clarification: a 2010 study examined bacterial contamination in collected urine specimens, not benefits or harms from drinking one's own urine.
Distinguished 360-day schematic arithmetic from the Egyptian 12×30+5 civil calendar and from physically measured Earth rotation.
Evidence update: a 2026 glioma systematic review included mostly nonrandomized ketogenic-diet studies. Dietary glucose regulation is not evidence that sugar removal cures an established cancer.
Added primary Thera radiocarbon findings and a full-methods 2025 Egyptian museum-object chronology comparison, with uncertainty and no assumed Exodus date.
Added another original 32-person acute physiologic experiment supporting a bounded hemodynamic signal, while maintaining no proven organ-specific clinical treatment. Verdict Unsupported / Low unchanged.
Clarification and bibliographic correction: clarified that terrain means the host biological environment and that this Investigation evaluates the strong germ-denialist claim; added documented 2020 and 2022 circulation examples as Claim Provenance, separate from Evidence Sources; corrected titles and publication classifications for 2024 PNAS, 2024 Annual Review of Microbiology, and 2025 WHO resources. Evidence Status unchanged.
Added the original 60-child papaya seed/honey randomized pilot outcomes and two transient treatment complaints; does not establish commercial multi-herb product efficacy. Verdict Unsupported / Moderate unchanged.
Integrated opposite-direction primary IBS stool-parasite findings by geography and organism, rather than treating positive stool detection as the cause of vague symptoms. Verdict Unsupported / Moderate unchanged.
Quantified the low-prevalence PCR confirmation study (52 first positives, 29 confirmed, 23 not), without treating nonconfirmation or high Ct as national analytical false-positive prevalence. Unsupported / Moderate unchanged.
Added original patient-flow and outcome denominators for the 2024 pancreatic and prostate IV-ascorbate adjunct trials, preserving a strict distinction from stand-alone cancer cure. Verdict Contradicted / Moderate unchanged.
Evidence-status correction: Earlier Inconclusive / Moderate could imply that clinically meaningful specific efficacy is supported at an actionable level. Re-review of original RCTs, competing meta-analyses and the independent 2024 Australian condition-specific GRADE evaluation supports Unsupported / Low for the affirmative therapeutic claim. Positive pooled and two low-certainty outcome signals remain reported; this does not mean every trial is negative or that efficacy is conclusively impossible.
Disclosed a recently published favorable-but-unblinded diagnostic study and distinguished 2023 government review preparation from its review-program title. Verdict Contradicted / Moderate unchanged.
Added 100/679 versus 111/679 TOGETHER composite outcomes, uncertainty and the prevention/treatment split in a 2026 randomized synthesis. Contradicted / High unchanged.
Included the published critical response to the Joshua eclipse identification and clear uncertainty of chronology and textual reading.
Clarified actual numerical simulation denominator and timescale, ancient-ephemeris model assumptions, and eclipse record coverage beginning 720 BCE.
Quantified 24-hour mineral release for four experimental ores; chemistry and patient benefit are separate claims. Verdict Misleading / Moderate unchanged.
Clarified that the quoted attributable risk estimates are for the combined myocarditis-or-pericarditis endpoint, with age, product, second-dose denominators and confidence intervals. Supported / High unchanged.
Historical-evidence clarification: Gall advanced localization as a research question, but later lesion and stimulation findings did not validate phrenological skull reading.
Added 2025 Egyptian museum-object chronology with denominator and calibration caveat and separated disease plausibility from verified sequence and cosmic trigger.
Evidence update: 2026 studies of sham design and a corrected small sham-controlled ICU trial were assessed, separately from the unverified healing-energy explanation.
Added the revised 2023 synthetic restriction-site preprint's statistical and recombination caveats and the opposing genomic analysis. Possibility is not proof of deliberate engineering; Unsupported / Moderate unchanged.
Clarified that 2024 Huanan environmental viral/wildlife DNA co-detection supports market-associated zoonosis but does not identify an infected animal or first spillover. Lab-related emergence remains unresolved; Inconclusive / Moderate unchanged.
Evidence update: a 22-person sweat assay documents measurable ions, but does not demonstrate lower systemic toxicant burden or clinical detoxification.
Detailed the Danish synthetic-control study's six comparable municipalities, local 31% case reduction estimate and testing/voluntary-behavior limits. Inconclusive / Low unchanged.
Clarified the scope of the 2018 intervention review: 113 studies across 17 foods, not evidence of a universal superfood category or clinical detox. Verdict Misleading / Moderate unchanged.
Factual source correction: an earlier Cochrane wound-healing review relied on four contested trials and was withdrawn in 2016 for serious concerns about their validity. It must not be counted as active clinical evidence.
Specified Minnesota COVID death-certificate validation counts (13,108 concordant, 483 missed and 413 over-attributed by study definition); local error does not determine national net overcount. Contradicted / Moderate unchanged.
Clarified distinction between fitted orbital models, 2,501 simulated distant-future outcomes, and independently observed Earth-rotation records.
Specified a dated historical highly eccentric planet-crossing interpretation of 'comet-like', excluding appearance-only descriptions and primordial migration.
Explicitly narrowed the historical Jovian-ejection Claim and corrected the overstatement of Venus isotope origin evidence.
Evidence clarification: added original prospective COSMOS study data with direct distinction between historical cellphone tumour endpoints and unmeasured 5G-specific risk; quantified the 2025 5G-era RF measurement study's units, frequency coverage, country-level scenarios and limitations. Evidence status unchanged.
Evidence interpretation update: clarified activated charcoal's limited role in selected acute poisonings and why adsorption under specific time-sensitive toxicology conditions does not support daily systemic detox supplementation.
Evidence update: added stress-exhaustion cortisol observations, a 2026 ME/CFS HPA synthesis concerning a different condition, and the published 2016 adrenal-fatigue review erratum (DOIs 10.1136/bmjopen-2012-001091, 10.1038/s41380-026-03608-1, 10.1186/s12902-016-0132-8). Evidence Status unchanged.
Evidence update: incorporated 2025–2026 retrospective oncology findings while separating urine from blood pH, diet from alkalizing agents and clinical associations from causation; a subgroup survival comparison used only 24 versus three people (DOI 10.3389/fonc.2026.1867616). Evidence Status unchanged.
Evidence update: included the 2022 French prospective cohort (102,865 adults; aspartame HR 1.15, 95% CI 1.03–1.28) and a separate positive 2026 observational signal. These associations do not establish cancer causation at ordinary approved exposures; outstanding original-study access limits remain disclosed.
Major original-evidence addition: 2016 randomized local bicarbonate-TACE comparator and 2025 n413 arterial bicarbonate-TACE cohort; 2016 survival-ITT nonsignificance, 2025 repeated imaging responses and cointerventions; no oral cancer-cure trial. Prior draft had understated local human study evidence; verdict for household oral cure unchanged.
Factual correction and evidence clarification: the 2014 MORA smoking-cessation pilot was previously called randomized, but the full paper describes alternating assignments; its positive self-reported one-year result and inconsistent denominators remain reported with limitations (DOI 10.1159/000365742). Evidence Status unchanged.
Evidence clarification: specified Wall et al. 2019 original Bluetooth-to-2G-handset comparison measures external RF power density (22 older handsets, headset 10–400 times lower), not personal tissue SAR or cancer incidence, and quantified indirect human phone cancer evidence limits. No change in status.
Evidence update: expanded sham-controlled and systematic-review results for non-musculoskeletal manipulation and included published methodological criticism of overgeneralizing null evidence. Broad systemic-disease causation or treatment effects remain unestablished.
Evidence interpretation update: clarified that the 2016 randomized cold-shower trial found fewer sickness-related absences (IRR 0.71) but no statistically significant reduction in days of illness (IRR 0.89); prevention of infections was not demonstrated (DOI 10.1371/journal.pone.0161749). Evidence Status unchanged.
Evidence update and clarification: added 2018, 2020 and September 2026 uncontrolled wet-cupping studies measuring blood-metal concentrations. The 2020 steelworker trial included 44 completers and reported lower levels for 10 of 13 metals; no study demonstrates that skin marks show toxins, controlled whole-body clearance or clinically beneficial detoxification. This exact claim remains Unsupported / Moderate.
Evidence update: expanded the direct 1996 ear-candling bench and clinical results, including the tested pressure mechanism, earwax findings and injury-report denominators. The evidence still contradicts the suction claim; reported injuries do not establish a population injury rate.
Factual correction (2026-10-09): our article previously cited a 2024 RF symptom review as 41 studies/2,874 participants. The authors' 2024 corrigendum (DOI 10.1016/j.envint.2024.108892) removed duplicate reporting of one experiment: 40 distinct studies/2,857 participants. Selected outcome estimates were corrected as well; the acute-blinded conclusion and Evidence Status are unchanged.
Evidence and scope clarification: evaluated general passive-EMF products separately for measured RF/SAR attenuation, operationally unspecified harmonization and human disease protection. Preserved the positive 2007 paramagnetic-disc report only at publisher-abstract access level; no product-specific efficacy verdict. Umbrella Evidence Status unchanged.
Evidence update and interpretation clarification: added the 2025 fluoride/IQ methodological criticism and author response plus updated hazard-versus-dose context, distinguishing high-exposure associations from community fluoridation at 0.7 mg/L, pineal-mediated harm or intentional population control.
Protocol and source clarification: NCT06699030 registry lists day-3 and day-6 ultrasound clearance as primary endpoints, while the published study protocol labels day-3 primary and day-6 secondary; dosing, delayed-active control and unresolved historical registry version documented. No posted trial outcomes or proof that classic flush lumps are gallstones; verdict unchanged.
Evidence update: incorporated a 2026 peer-reviewed controlled human pertussis exposure study and a separate non-peer-reviewed 2026 symptom preprint; colonization, symptomatic infection and host susceptibility remain distinct endpoints (DOIs 10.1016/j.lanmic.2025.101313, 10.64898/2026.06.09.26355227). Evidence Status unchanged.
Evidence update: added population-based bereavement research (21,062 bereaved parents and 293,745 controls) while distinguishing modest stress-related associations from the unvalidated fixed Hamer conflict-to-cancer map (DOI 10.1002/cncr.10943). Evidence Status unchanged.
Evidence update: added blinded gluten/fructan/placebo challenge evidence and distinguished established gluten-related conditions from the universal-harm claim. The 59-person sample cannot be generalized to everyone.
Evidence update: incorporated 2025 controlled postoperative and sleep-mat studies, noting baseline imbalance, inconsistent CRP units and irreconcilable participant counts; chronic-disease treatment remains unproven (DOIs 10.3390/jcm14113844, 10.1016/j.aimed.2025.01.005). Evidence Status unchanged.
Technical clarification: added primary ICNIRP 2020 guideline and its distinct basic restrictions and external reference levels, with units, different spatial/temporal averaging requirements and near-field cautions. No change to the conclusion that a consumer RF reading alone cannot diagnose medical danger.
Evidence interpretation update: translated measured trace minerals into a realistic 5 g salt intake and distinguished small mineral amounts from sodium exposure and the iodine tradeoff. Mineral composition alone does not establish superior clinical outcomes.
Original-evidence and replication update: added blinded 2005/2009 arsenic-wheat studies with reversed or unreproduced effects, Endler 2015 bibliometric follow-up and previously omitted high-dilution reviews; overlapping datasets, basophil and plant model controls, full-text limitations and absence of a validated substance-specific water-memory mechanism made explicit. Verdict Unsupported / Quality Moderate unchanged.
Evidence update: expanded full original 2015 physiology measurements; cerebral oxygenation and blood flow fell during short hyperventilation near sea level but the cerebral oxygenation response differed at extreme altitude; 12 participants initially, nine on day 2 and seven on day 7 at altitude (DOI 10.1016/j.wem.2014.10.001). Evidence Status unchanged.
Evidence update: added a 2025 fourteen-participant juice-diet microbiome study while distinguishing microbial composition changes from named-toxin clearance or patient-relevant detoxification; clinical toxin-clearance trial coverage remains incomplete.
Status-calibration/source-status update: publisher listing currently flags Speicher et al. 2025 under investigation and separately says minor corrections do not change academic content; exact corrected passages inaccessible for line-by-line review. No human chromosomal-insertion claim proven; Evidence Quality remains moderate.
Evidence update and scope clarification: added original U.S. raw-milk outbreak surveillance and its missing per-serving risk denominator, while acknowledging observational farm-milk/asthma findings and farm-environment confounding. The blanket safety and nutritional-superiority claim remains contradicted.
Evidence update: added separate 2011 n=41 and 2023 n=66 uncontrolled liver-cancer amplitude-modulated electromagnetic studies; neither tested historical/commercial Rife machines or proved cancer cures (DOIs 10.1038/bjc.2011.292, 10.1002/cam4.5944). Evidence Status unchanged.
Evidence clarification: quantified original 2025 paraffin/shungite waveguide geometry, 0–50% filler, transmission/reflection values, and distinguished engineered shielding from unmeasured decorative loose-stone user exposure. No change in Misleading / Moderate conclusion.
Evidence and scope clarification: separated residential smart-meter cancer incidence from recurring-headache causation, retained heterogeneous 868/902–928/915-MHz dosimetry and the 81-meter-bank counterexample, and distinguished >88,000 utility meter logs from clinical participants. Umbrella status unchanged.
Evidence clarification: added original 2024 Wi-Fi/IoT household exposure measurements and disclosed their industry sponsorship while differentiating router-origin RF reduction, whole-person exposure and unmeasured cancer-incidence benefit. No change in verdict.
Scientific calibration: Evidence Quality lowered from High to Moderate on the research draft because the 2026 fertility umbrella review rates its pre-2024 evidence very-low-to-low, outcomes are heterogeneous and original inactivated-vaccine FET cohorts conflict; broad 'commonly persistent infertility' verdict Misleading unchanged.
Interim scientific-calibration record: the inherited High Evidence Quality was provisional given endpoint heterogeneity and low-certainty review findings. It was subsequently changed to Moderate on October 9 after outcome-specific review; the Misleading verdict was retained.
Evidence clarification: supplied original study denominators and frequency scope for 2007 Wi-Fi measurements, and added 2024 measured/modeled smart-home RF exposure with its industry funding and limits; neither supplies household cancer incidence. Evidence Status unchanged.
Evidence update: added 2026 multiple-sclerosis three-arm trial (60 assigned; 43 completers) and separated exploratory immune biomarkers from unproven improvement in disease outcomes (DOI 10.1007/s10072-026-08895-8). Evidence Status unchanged.
Evidence and scope clarification: separated the historical Bluetooth-versus-active-phone external RF power-density comparison from clinically confirmed brain-tumour causation; retained the 2024 thyroid-nodule survey solely as a different exploratory outcome and preserved the distinction from brain SAR.
Scope clarification and expanded evidence review: the original article combined meridian anatomy, distinctive channels and acupuncture-point properties. This revision tests correspondence of traditional route maps to known anatomical structures versus matched control routes. Two separate Investigations now assess physical network identity and point-specific features. Evidence status stays Inconclusive and quality stays Low.
Evidence update: newly available 2026 blinded ACV-and-metformin placebo trial and original 2020 metformin-adjunct comparison added; synthesis and retraction limitations remain, verdict unchanged.
Evidence update: 2026 local bicarbonate plus anti-PD-1 cohort analyzed; clarified conflicting clinical administration-route wording and absence of oral-cure evidence. Verdict unchanged.
Evidence update: original fungal-tumor studies and opposing methodological reanalyses added, with shared sample provenance disclosed; verdict unchanged.
Evidence update: 2023 randomized commercial supplement trial added with actual active-control and biomarker-inference limitations; verdict unchanged.
Scope clarification: evaluates whether evidence demonstrates additional elimination of identified harmful substances by consumer detox products, without asserting that every possible product is ineffective.
Evidence update: prospective sugar-sweetened beverage associations separated from causal claims about isolated sugar and cancer, with preprint status disclosed; verdict unchanged.
Evidence update: original uncontrolled case reports and two registered but unreported herbal electrohomeopathy trials distinguished from demonstrated placebo-controlled benefit; verdict unchanged.
Evidence update: direct randomized oncology outcomes, primary versus secondary endpoints, and uncertain clinical progression benefit distinguished; verdict unchanged.
Evidence update: bounded human oncology trial inventory distinguishes fasting alongside treatment from fasting as sole cancer therapy; verdict unchanged.
Evidence update: human autophagic-flux pilot and randomized-substudy assay data and their limits for clinical causation clarified; verdict unchanged.
Evidence update: conflicting observational mortality cohorts and short-term fasting RCTs distinguished from direct causal evidence of human longevity; verdict unchanged.
Evidence update: small early-feeding signals contrasted with a later calorie-matched controlled intervention; limits of inaccessible secondary glucose results made explicit; verdict unchanged.
Evidence update: added distinct 2024 UDCA-plus-omega-3 randomized trial and 2026 microlithiasis protocol, with statistical and treatment-scope caveats; verdict unchanged.
Scope clarification: focuses on the identity of characteristic green stool masses; medically measured gallstone dissolution and toxin elimination require separate evidence.
Evidence update: original anti-IgE and histamine high-dilution basophil experiments added with opposing results, blinding and control-design limits; verdict unchanged.
Evidence update: original opposing 2025 vial-DNA measurements, 2026 methodological critique, and publisher investigation status added; genome-integration conclusion unchanged.
Evidence update: original pan-cancer genomic data and the randomized 2025 ROME trial added, with clarified scope and patient outcomes; verdict unchanged.
Evidence update: added original U.S. VSD 2022 positive asthma association alongside contrary Danish 2025 cohort and correction, BMJ 2026 review, and same-cohort 2026 reanalysis; observational effects and deliberate intent assessed separately. Verdict unchanged.
**Clarification and evidence update:** The 2014 meta-analysis's 1,256,407 represents summed cohort-study enrollment counts, not a verified deduplicated number of unique children; some contributing older Danish cohorts share birth-year eligibility. The 2026 WHO final review and large vaccine-specific populations remain central to the conclusion. No change to **Contradicted / High**.
Evidence update: contradictory 2022–2026 primary FET/ART cohorts and natural fecundability outcomes analyzed; selection, timing and sterilization intent separated; verdict unchanged.
Scope clarification: evaluates persistent infertility in previously fertile people; allegations of deliberately engineered sterilization are separate from the biological question.
Evidence update: added original 2019 optical microneedle vaccine-history research and clarified its preclinical scope; verdict unchanged.
Evidence update: original short-term crossover comparisons and the limitations of meal-specific glucose AUC versus long-term disease outcomes clarified; verdict unchanged.